Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anneser, J. M.H.
Right arrow Articles by Schoser, B. G.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anneser, J. M.H.
Right arrow Articles by Schoser, B. G.H.
Related Collections
Right arrow Peripheral neuropathy
NEUROLOGY 2005;64:368-370
© 2005 American Academy of Neurology


Brief Communications

Mutations in the acid {alpha}-glucosidase gene (M. Pompe) in a patient with an unusual phenotype

J. M.H. Anneser, MD, D. E. Pongratz, MD, T. Podskarbi, MD, Y. S. Shin, PhD and B. G.H. Schoser, MD

From the Department of Neurology and Friedrich-Baur-Institute (Drs. Anneser, Pongratz, and Schoser), Ludwig-Maximilians-University, Munich; The Institute of Metabolic Genetic Disease (Dr. Podskarbi), Munich; and Children’s Hospital (Dr. Shin), University of Munich, Germany.

Address correspondence and reprint requests to Dr. Johanna M.H. Anneser, Department of Neurology, University of Munich, Klinikum Grosshadern, D-81366 Munich, Germany; e-mail: Johanna.Anneser{at}nro.med.uni-muenchen.de

Glycogenosis type II (Pompe disease) is a lysosomal storage disease caused by deficiency of acid {alpha}-glucosidase (acid maltase). The disease is autosomal recessive inherited and is clinically and genetically heterogenous. The authors describe a 30-year-old woman affected by late-onset Pompe disease with vascular affection resembling atherosclerotic angiopathy of the elderly. Genetic analysis revealed two novel mutations (Ala237Val and Gly293Arg) in the acid {alpha}-glucosidase gene in this patient.


Received April 13, 2004. Accepted in final form September 6, 2004.




This article has been cited by other articles:


Home page
NeurologyHome page
B. Bembi, E. Cerini, C. Danesino, M. A. Donati, S. Gasperini, L. Morandi, O. Musumeci, G. Parenti, S. Ravaglia, F. Seidita, et al.
Management and treatment of glycogenosis type II
Neurology, December 2, 2008; 71(23_suppl_2): S12 - S36.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Laforet, P. Petiot, M. Nicolino, D. Orlikowski, C. Caillaud, N. Pellegrini, R. Froissart, T. Petitjean, I. Maire, H. Chabriat, et al.
Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease
Neurology, May 27, 2008; 70(22): 2063 - 2066.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.